Siemens denies breakup plans

Article

Siemens AG scrambled to deny a report this week in the Financial Times German edition that the company is planning “a radical restructuring.” The article implied that Siemens might sell several divisions, including its medical technology

Siemens AG scrambled to deny a report this week in the Financial Times German edition that the company is planning “a radical restructuring.” The article implied that Siemens might sell several divisions, including its medical technology business, in order to focus on information technology and communications.

In a press release issued by Siemens’ corporate headquarters in Erlangen, the company said statements attributed to CFO Heinz-Joachim Neubùrger were “distorted” and that a “radical restructuring” is not in the works. Specifically, Siemens said divestment of its energy, transportation, and healthcare segments was not being considered. In fact, healthcare is the company’s fifth-most-profitable business segment, according to Joe Camaratta, VP of marketing for Siemens Medical Systems in Iselin, NJ.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.